Northern Trust’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,008
Closed -$10K 4805
2021
Q3
$10K Sell
1,008
-748
-43% -$7.42K ﹤0.01% 4625
2021
Q2
$17K Sell
1,756
-1,204
-41% -$11.7K ﹤0.01% 4548
2021
Q1
$35K Sell
2,960
-9,121
-75% -$108K ﹤0.01% 4411
2020
Q4
$432K Buy
12,081
+8,999
+292% +$322K ﹤0.01% 3758
2020
Q3
$43K Sell
3,082
-9
-0.3% -$126 ﹤0.01% 4123
2020
Q2
$51K Sell
3,091
-191
-6% -$3.15K ﹤0.01% 4054
2020
Q1
$28K Sell
3,282
-7,518
-70% -$64.1K ﹤0.01% 4045
2019
Q4
$245K Sell
10,800
-202
-2% -$4.58K ﹤0.01% 3733
2019
Q3
$158K Sell
11,002
-25,916
-70% -$372K ﹤0.01% 3817
2019
Q2
$491K Sell
36,918
-1,517
-4% -$20.2K ﹤0.01% 3551
2019
Q1
$667K Sell
38,435
-316
-0.8% -$5.48K ﹤0.01% 3466
2018
Q4
$529K Sell
38,751
-2,434
-6% -$33.2K ﹤0.01% 3538
2018
Q3
$886K Buy
41,185
+669
+2% +$14.4K ﹤0.01% 3502
2018
Q2
$1.74M Sell
40,516
-993
-2% -$42.5K ﹤0.01% 3271
2018
Q1
$2.71M Sell
41,509
-119
-0.3% -$7.77K ﹤0.01% 2953
2017
Q4
$3.04M Buy
41,628
+8,286
+25% +$605K ﹤0.01% 2891
2017
Q3
$3.06M Buy
33,342
+149
+0.4% +$13.7K ﹤0.01% 2926
2017
Q2
$2.2M Buy
33,193
+1,281
+4% +$84.7K ﹤0.01% 3115
2017
Q1
$6.92M Buy
31,912
+887
+3% +$192K ﹤0.01% 2357
2016
Q4
$2.87M Buy
31,025
+735
+2% +$68K ﹤0.01% 2889
2016
Q3
$4.09M Buy
30,290
+339
+1% +$45.8K ﹤0.01% 2645
2016
Q2
$3.04M Buy
29,951
+2,672
+10% +$271K ﹤0.01% 2797
2016
Q1
$4.47M Buy
27,279
+300
+1% +$49.1K ﹤0.01% 2478
2015
Q4
$8.84M Buy
26,979
+893
+3% +$292K ﹤0.01% 2099
2015
Q3
$8.41M Buy
26,086
+1,271
+5% +$410K ﹤0.01% 2114
2015
Q2
$9.89M Sell
24,815
-48
-0.2% -$19.1K ﹤0.01% 2074
2015
Q1
$12.2M Buy
24,863
+593
+2% +$292K ﹤0.01% 1945
2014
Q4
$8.68M Sell
24,270
-687
-3% -$246K ﹤0.01% 2135
2014
Q3
$4.81M Buy
24,957
+1,085
+5% +$209K ﹤0.01% 2532
2014
Q2
$5.7M Sell
23,872
-875
-4% -$209K ﹤0.01% 2423
2014
Q1
$6.33M Sell
24,747
-2,162
-8% -$553K ﹤0.01% 2412
2013
Q4
$5.33M Buy
26,909
+600
+2% +$119K ﹤0.01% 2521
2013
Q3
$4.45M Buy
26,309
+2,069
+9% +$350K ﹤0.01% 2585
2013
Q2
$4.3M Buy
+24,240
New +$4.3M ﹤0.01% 2521